Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Oncologix Tech, Inc. (OTC: OCLG).

Full DD Report for OCLG

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A0.0001N/AN/A0
2018-12-13N/A0.0001N/AN/A0
2018-12-120.00010.00010.00010.0001600
2018-12-110.00010.00010.00010.00016,000
2018-12-10N/A0.0001N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-072,190,63219,690,63211.1252Cover
2018-12-062,000,0004,000,00050.0000Short
2018-11-271,687,2432,845,88859.2870Short
2018-11-154,497,23034,209,42413.1462Cover
2018-11-1219,00019,000100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on OCLG.


About Oncologix Tech, Inc. (OTC: OCLG)

Logo for Oncologix Tech, Inc. (OTC: OCLG)

Oncologix is a diversified medical holding company that operates and manufactures Class II medical device products, delivers Personal Health Care Services, and sells and distributes Durable and Home Medical Equipment. For its clients, Oncologix provides FDA approved medical devices, state licensed healthcare services, and medical products and technologies. For its shareholders, Oncologix operates profitable divisions that build, maintain and nourish all shareholder value. The Company s corporate mission is to be the best small cap medical holding company in North America.

 

 

 

Current Management

  • Michael Kramarz / Acting CEO, Acting CFO
    • Mr. Kramarz was first employed by the Company in September , as its Controller and now has over combined years working for public companies. Mr. Kramarz is responsible for all financial statement, accounting, SEC compliance, payroll and tax functions. From to , Mr. Kramarz was employed as Accounting Manager for Assurant Group, a billion dollar insurance company. Mr. Kramarz was responsible for the accounting, budgeting and payroll functions of one of Assurant Group s million dollar call center subsidiaries with offices in Michigan and Oklahoma. In addition, Mr. Kramarz was responsible for quarterly consolidations into the parent company to assist with its SEC and tax filings. From to , Mr. Kramarz was a staff accountant at VandenToorn amp Associates CPA firm where he was responsible for compilations and reviews of financial statements, as well as tax return preparation. Mr. Kramarz holds a Certified Management Accountant Designation CMA and a Certified Public Accountant Designation CPA . Mr. Kramarz holds a Bachelor of Science and Business Administration in Accounting from Aquinas College and a Masters in the Science of Taxation from Grand Valley State University.
  • Roy W. Erwin / President, Subsidiary
    • Erwin has been the Chief Executive Officer of Deep South Capital, LLC., a company with very limited operations. From to , Mr. Erwin was the cofounder and Chief Operations Officer of Electronic Health Network, a leader in Healthcare and Medical Information Technology. From to he was the Chief Operating Officer and Director of New Business Development at Crossroads Regional Hospital, a bed, acute care, inpatient and outpatient psychiatric and Substance Abuse Facility. From to , Mr. Erwin was the Regional Director of Sales for Centerpulse Orthopedics, Inc, a Division of Sulzer Corporation, a worldwide, . billion Swiss conglomerate specializing in orthopedic total joint reconstruction of hip, knees and shoulder products. Prior to , Mr. Erwin was employed by Valley Lab, Inc., Ball Aerospace and Texas Instruments in various senior management capacities. He served in the US Army, with the rank of Captain, at the st Airborne Division, with overseas assignments in Panama and Honduras and has advanced military training in Air Borne, Air Assault, and Jungle Warfare training. Wayne graduated with a Bachelor of Science from Louisiana College Pineville, Louisiana.
  • Harold Halman / COO
    • Mr. Halman brings years of new business development, medical sales, marketing and operations experience to OCLG. Prior to joining the company, Harold was the Chief Executive Officer for Global Medical located in Phoenix, Arizona, a national provider for home medical equipment. Mr Halman has vast knowledge and direct industry experience in medical devices and home medical products that will accelerate expansion within the Company s Medical Products and Technology Division both domestically and internationally. Prior to Global Medical, Mr. Halman was CEO of his management consulting firm involved in M amp A, business turnarounds and business development projects. His direct experience includes bringing forth breakthrough medical products and technologies to the market with aggressive, multitiered distribution strategies.
  • Michael Kramarz / Chairman, Compensation Committee Member
    • Mr. Kramarz was first employed by the Company in September , as its Controller and now has over combined years working for public companies. Mr. Kramarz is responsible for all financial statement, accounting, SEC compliance, payroll and tax functions. From to , Mr. Kramarz was employed as Accounting Manager for Assurant Group, a billion dollar insurance company. Mr. Kramarz was responsible for the accounting, budgeting and payroll functions of one of Assurant Group s million dollar call center subsidiaries with offices in Michigan and Oklahoma. In addition, Mr. Kramarz was responsible for quarterly consolidations into the parent company to assist with its SEC and tax filings. From to , Mr. Kramarz was a staff accountant at VandenToorn amp Associates CPA firm where he was responsible for compilations and reviews of financial statements, as well as tax return preparation. Mr. Kramarz holds a Certified Management Accountant Designation CMA and a Certified Public Accountant Designation CPA . Mr. Kramarz holds a Bachelor of Science and Business Administration in Accounting from Aquinas College and a Masters in the Science of Taxation from Grand Valley State University.

Current Share Structure

  • Market Cap: $154,623 - 03/16/2018
  • Authorized: 7,000,000,000 - 11/30/2017
  • Issue and Outstanding: 773,115,725 - 11/30/2017

 


Recent Filings from (OTC: OCLG)

Quarterly Report - Oncologix Tech Inc. Quarterly Report
Filing Type: Quarterly Report - Oncologix Tech Inc. Quarterly ReportFiling Source: OTC Markets
Filing Date: January, 16 2018
Attorney Letter with Respect to Current Information - Attorney Letter on Current Information
Filing Type: Attorney Letter with Respect to Current Information - Attorney Letter on Current InformationFiling Source: OTC Markets
Filing Date: December, 05 2017
Annual Report - Oncologix Tech Inc. Annual Report
Filing Type: Annual Report - Oncologix Tech Inc. Annual ReportFiling Source: OTC Markets
Filing Date: November, 30 2017
Supplemental Information - Information Statement Regarding Oncologix Tech Inc. Increase in Authorized Common Stock
Filing Type: Supplemental Information - Information Statement Regarding Oncologix Tech Inc. Increase in AuthorizeFiling Source: OTC Markets
Filing Date: September, 15 2017
Attorney Letter with Respect to Current Information - Attorney Letter on Current Information All Periods
Filing Type: Attorney Letter with Respect to Current Information - Attorney Letter on Current Information All PerFiling Source: OTC Markets
Filing Date: September, 07 2017

 

 


Daily Technical Chart for (OTC: OCLG)

Daily Technical Chart for (OTC: OCLG)


Stay tuned for daily updates and more on (OTC: OCLG)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: OCLG)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in OCLG is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of OCLG and does not buy, sell, or trade any shares of OCLG. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/